908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates

Group 1 - 908 Devices Inc. reported a quarterly loss of $0.22 per share, better than the Zacks Consensus Estimate of a loss of $0.27, and an improvement from a loss of $0.33 per share a year ago, resulting in an earnings surprise of 18.52% [1] - The company posted revenues of $11.78 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 2.99%, but showing growth from $9.99 million in the same quarter last year [2] - 908 Devices shares have increased approximately 160.5% since the beginning of the year, contrasting with a decline of 0.6% in the S&P 500 [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is -$0.18 on revenues of $12.3 million, and for the current fiscal year, it is -$0.63 on revenues of $55.48 million [7] - The Medical - Instruments industry, to which 908 Devices belongs, is currently ranked in the top 31% of over 250 Zacks industries, indicating a favorable outlook for stocks in this sector [8]